SRMA of the Effect of Soy Milk vs Cow's Milk on Cardiometabolic Outcomes
Launched by UNIVERSITY OF TORONTO · Nov 28, 2022
Trial Information
Current as of January 16, 2025
Active, not recruiting
Keywords
ClinConnect Summary
RATIONALE. Soymilk and other processed soy products are at an important crossroads. Although the DGA, Health Canada, and various pediatric associations recognize fortified soymilk as the only non-dairy plant milk alternative equivalent to cow's milk and it can carry an approved health claim for coronary heart disease risk reduction based on the soy protein that it contains, soymilk is classified by the NOVA classification as an ultra-processed food (the opposite of the classification of cow's milk as an unprocessed or minimally processed food). To be an acceptable iso-sweet alternative to c...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Randomized controlled trials
- • Soy milk intervention
- • Cow's milk comparator
- • Intervention duration ≥ 3 weeks
- • Data for at least 1 outcome
- Exclusion Criteria:
- • Non-human studies
- • Observational studies
- • Acute single-bolus feeding studies
- • Participants \< 18 years of age
- • Multimodal interventions
- • Lack of suitable comparator
- • Intervention duration \< 3 weeks
- • No viable outcome data
Trial Officials
John L. Sievenpiper, MD,PhD,FRCPC
Principal Investigator
University of Toronto
About University Of Toronto
The University of Toronto, a prestigious research institution, serves as a leading sponsor of clinical trials dedicated to advancing medical knowledge and improving patient care. With a commitment to innovation and excellence, the university fosters a collaborative environment that brings together multidisciplinary teams of experts in medicine, pharmacology, and public health. Through rigorous research methodologies and ethical standards, the University of Toronto aims to explore new therapies, assess treatment efficacy, and address critical health challenges, ultimately contributing to the global body of scientific knowledge and enhancing healthcare outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials